- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Chronic heart failure
- Meeting Date: July 2022
- Public Summary Document (PSD) July 2022 PBAC Meeting - (PDF 599KB)
- Public Summary Document (PSD) July 2022 PBAC Meeting - (Word 79KB)
Vericiguat – July 2022
Vericiguat: Tablet 2.5 mg, Tablet 5 mg, Tablet 10 mg; Verquvo®
Last updated
28 October 2022